Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Work In Process (2018 - 2025)

Historic Work In Process for Jaguar Health (JAGX) over the last 8 years, with Q3 2025 value amounting to $7.4 million.

  • Jaguar Health's Work In Process rose 566.41% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 566.41%. This contributed to the annual value of $7.4 million for FY2024, which is 1365.66% up from last year.
  • Jaguar Health's Work In Process amounted to $7.4 million in Q3 2025, which was up 566.41% from $7.6 million recorded in Q2 2025.
  • Jaguar Health's 5-year Work In Process high stood at $7.7 million for Q1 2025, and its period low was $1.5 million during Q1 2021.
  • In the last 5 years, Jaguar Health's Work In Process had a median value of $5.4 million in 2023 and averaged $4.9 million.
  • As far as peak fluctuations go, Jaguar Health's Work In Process skyrocketed by 30627.31% in 2021, and later skyrocketed by 566.41% in 2025.
  • Quarter analysis of 5 years shows Jaguar Health's Work In Process stood at $2.8 million in 2021, then skyrocketed by 30.4% to $3.6 million in 2022, then surged by 81.08% to $6.5 million in 2023, then grew by 13.66% to $7.4 million in 2024, then dropped by 0.01% to $7.4 million in 2025.
  • Its last three reported values are $7.4 million in Q3 2025, $7.6 million for Q2 2025, and $7.7 million during Q1 2025.